Abstract
Pharmaceutical CME departments struggle to measure performance for a number of
reasons. The lack of hard measures for medical education, along with a fear of
appearing non-compliant stops many companies from tracking return on
investment (ROI). Many medical education departments use post-CME outcomes
measures to judge the effectiveness of their investments in CME events.
Unfortunately, attendance figures are the only hard measurement available from
outcomes measurements - and high attendance numbers do not always translate
into effective programs.
Cutting Edge Information' s study presents best practices and strategies for
measuring CME program effectiveness, as well as explores the recent changes
that pharmaceutical CME teams have undergone since the Office of Inspector
General (OIG) published its guidance document in 2003. The study is a
comprehensive look at the pharmaceutical industry' s strategies and support for
CME in the current compliance environment.
Pharmaceutical CME: Measuring Program Effectiveness in the Compliance
Environment explores the current challenges facing continuing medical
education, as well as includes trend analysis, successful strategies and best
practices. The study' s major focus areas include:
- CME Structure, Staffing and Spending - Cutting Edge Information
collected case studies and benchmark data to underscore CME investment trends
and reorganization strategies to remain compliant with industry regulations.
- CME Program Strategies and Goals - Analysts compared
industry-leading strategies and outlined goals for CME departments.
- Grants Process - Our study identifies best practices in
standardizing the CME grants request process. The study also outlines changes
in the process to meet with new compliance standards.
- Evaluating Program Management and Effectiveness - The most
effective CME departments in the pharmaceutical industry invest in various
vehicles to deliver medical education to target physician audiences. Cutting
Edge Information compiled best practices and industry trends regarding the
ideal CME media mix, including live events, eCME and enduring content.
- Performance Measurement - Our analysts took a strategic look at
hard and soft measures that pharma companies use to determine return on
investment and return on education.
- CME Compliance - The study outlines top compliance challenges and
presents solutions for pharmaceutical companies to operate effective CME
programs in an ever-changing compliance environment.
View Cart
